Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Gujarat Inject (Kerala) Ltd

BSE: 524238 · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹9.48
Market cap
₹138.9 Cr
Revenue (annual)
₹36.32 Cr
Net profit (annual)
₹1.81 Cr
P/E (TTM)
46.4×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:50 IST BSE
Management Change

Gujarat Inject (Kerala) Management Change

Gujarat Inject Kerala Ltd has appointed M/s. S N D K & Associates LLP as the company's new Statutory Auditor. The appointment is effective from September 29, 2026.

18:47 IST BSE
Management Change

Gujarat Inject (Kerala) Management Change

Gujarat Inject (Kerala) Limited has appointed Mr. Radadiya HardikKumar AnilBhai as the Chief Financial Officer and Key Managerial Personnel, effective August 10, 2026.

17:44 IST BSE
Management Change

Gujarat Inject (Kerala) Management Change

Gujarat Inject Kerala Ltd appointed Mr. Murli Shivshankaran Nair as Managing Director effective 06th July 2026. His 3-year term begins pending shareholder approval.

Execution
3 years
17:22 IST BSE
Management Change

Gujarat Inject (Kerala) Management Change

Gujarat Inject Kerala Ltd reported the demise of Chairman, CFO, and Whole-Time Director Deepak Diwan Bachwani. He ceased his roles on June 23, 2026.

19:18 IST BSE
Management Change

Gujarat Inject (Kerala) Management Change

Gujarat Inject Kerala Ltd announced the resignation of MD Murli Nair and appointment of Deepak Bachwani as Chairman. The leadership transition takes effect from May 16, 2026.